China-based CGM developer Sinocare recently announced a significant legal victory over Abbott, a market leader in the CGM space. Our sister site, Drug Delivery Business News, reports that a judge in the High Court of Justice (Chancery Division) of England and Wales rejected claims of trademark infringement and passing off made by Abbott against Sinocare. According […]
Sinocare
Report: Chinese bidders eye Johnson & Johnson’s diabetes biz
Chinese glucose monitor maker Sinocare (SZ:300298) and a sovereign wealth fund there are said to be in the hunt for the diabetes business Johnson & Johnson (NYSE:JNJ) is looking to unload. The New Brunswick, N.J.-based healthcare conglomerate early last year announced a strategic review of its LifeScan, Animas and Calibra Medical diabetes businesses and later elected to […]
Sinocare closes $273m Nipro buy
Nipro (TYO: 8086) said today it closed the $273 million sale of its diagnostics business to China-based Sinocare, which renamed the newly acquired company to Trividia Health. Former Nipro Diagnostics CEO and chair Scott Verner will stay on as CEO and prez of Trividia health, joined by “key executives” from the current management team, according to the press release. […]
Nipro to sell diagnostics biz to China’s Sinocare for $273m
Nipro (TYO: 8086) said today it signed a deal sell its diagnostics business to China-based Sinocare for approximately $273 in cash. Nipro Diagnostics, based in Ft. Lauderdale, Fla., develops, manufactures and markets diabetes products, including glucose monitors, the company said. “This transaction combines 1 of the fastest growing blood glucose monitoring companies in the United States with […]
